Veraxa Biotech is trading at $1.04, up 9.47%, with sector strength the likeliest explanation; no fresh company-specific announcement was identified.
- Biotech shares were up 2.08% pre-market, supported by positive industry sentiment and Amgen earnings context.
- The official investor-relations page lists October 13 as its latest release.
- Recent closes had slipped to $0.95 on November 4, after losses on November 2 and 3.